PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models.
Wong CW, Evangelou C, Sefton KN, Leshem R, Zhang W, Gopalan V, Chattrakarn S, Fernandez Carro ML, Uzuner E, Mole H, Wilcock DJ, Smith MP, Sergiou K, Telfer BA, Isaac DT, Liu C, Perl NR, Marie K, Lorigan P, Williams KJ, Rao PE, Nagaraju RT, Niepel M, Hurlstone AFL.
Wong CW, et al. Among authors: wilcock dj.
Nat Commun. 2023 Sep 26;14(1):5983. doi: 10.1038/s41467-023-41737-1.
Nat Commun. 2023.
PMID: 37752135
Free PMC article.